Mission

Diatos is a biopharmaceutical company developing innovative therapies for unmet medical needs in cancer.

Diatos leverages its peptide-based, intracellular drug delivery & tumor targeting technologies to improve the properties of existing therapeutics as well as enable new therapies by increasing efficacy, optimizing dosage and reducing toxicity and adverse effects. Diatos also develops high-quality in-licensed oncology therapeutics.